The Impact of High-Risk Cytogenetic Abnormalities in Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights from a Multicenter Study
BMC CANCER(2024)
Key words
Extramedullary multiple myeloma,High risk cytogenetic abnormalities,CD38 monoclonal antibody,Transplantation,1q gain/amplification
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined